MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$56,391K Prepaid expenses andother current assets$3,429K Accounts receivable$168K Total current assets$59,988K Operating leaseright-of-use assets$2,035K Other assets,noncurrent$500K Property and equipment,net$163K Total assets$62,686K Accumulated deficit-$951,517K Total liabilities andstockholders deficit$62,686K Total stockholdersdeficit-$59,537K Additional paid-in capital$891,980K Total liabilities$122,223K Deferred revenue,noncurrent$78,954K Total currentliabilities$43,269K Deferred revenue$23,770K Accrued expenses$14,813K Accounts payable$2,393K Operating leaseliabilities$2,293K
Balance Sheet
source: myfinsight.com

Mersana Therapeutics, Inc. (MRSN)

Mersana Therapeutics, Inc. (MRSN)